Clinical TrialsSearch results for "trabectedin"
Number of results: 11
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
- Advanced Solid Tumor
- Suzuki Tomoya
- 2024-10-24
Recruiting
- Study on efficacy of doxorubicin and <em>trabectedin</em> combination therapy
- Soft tissue sarcoma
- Fujibuchi Taketsugu
- 2024-10-08
Other
- Clinical Trial of Lurbinectedin as Single-agent or in Combination with Irinotecan Versus Topotecan or Irinotecan in Patients with Relapsed Small-cell Lung Cancer
- Relapsed Small Cell Lung Cancer
- Kobayashi Takeshi
- 2024-03-13
Other
- JCOG1802: A randomized phase II trial of 2nd line treatment for advanced soft tissue sarcoma comparing <em>trabectedin</em>, eribulin and pazopanib
- Advanced soft tissue sarcoma
- TANAKA Kazuhiro
- 2019-12-05
Other
- Clinical outcome of <em>trabectedin</em> in Japanese patients with soft tissue sarcoma; JMOG multicenter study
- Malignant soft tissue tumor
- Japanese Musculoskeletal Oncology Group
- 2018-09-21
Other
- A Phase I study of patients with advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer
- Patients with epithelial ovarian, primary peritoneal, or fallopian tube cancer
- Taiho Pharmaceutical Co., Ltd.
- 2016-02-22
Other
-
- Patients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocations
- Taiho Pharmaceutical Co., Ltd.
- 2014-04-18
Other
-
- Patients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocations
- Taiho Pharmaceutical Co., Ltd.
- 2012-06-04
- 1